原发性肺动脉高压指肺小动脉原发增生性病变所致的闭塞性肺动脉高压,其病因可能是多方面的,先天性的肺小动脉病变是其中之一。
...什么是原发性肺动脉高压? 什么是原发性肺动脉高压?原发性肺动脉高压是怎么回事?原发性肺动脉高压(primary pulmonary hypertension)是一少见疾病, 原发性肺动脉高压的症状,原发性肺动脉高压怎么治疗?如何预防原发性肺动脉高压?
基于1262个网页-相关网页
primary pulmonary hypertension PPH: 原发性肺动脉高压 Primary Pulmonary Arterial Hypertension: 原发性肺动脉高压 familial primary pulmonary hypertension: 家族性原发性肺动脉高压 ..
基于24个网页-相关网页
对于原因不明的肺动脉高压称为原发性肺动脉高压(Idiopathic pulmonary arterial hypertension,IPAH).肺动脉高压严重影响疾病的进展及预后,阐明其发病理论已成为该领域亟待解决的重要课题.
基于2个网页-相关网页
称为原发性肺动脉高压 primary pulmonary hypertension
原发性肺动脉高压症 primary pulmonary hyperbaric ; primary pulmonary hypertension
为原发性肺动脉高压 primary pulmonary hypertension
原发性肺动脉高压组 primary pulmonary hypertention
将原发性肺动脉高压 primary pulmonary hypertension
在原发性肺动脉高压 primary pulmonary hypertension
原发性肺动脉高血压 primary pulmonary hypertension
前言:目的:介绍治疗原发性肺动脉高压的吸入性伊洛前列素。
Objective: To introduce inhaled iloprost for the treatment of primary pulmonary hypertension.
目的:分析儿童原发性肺动脉高压的临床资料,为临床准确、及时的诊断本病提供依据。
Objective: To analyze the clinical data of primary pulmonary hypertension in children and improve its clinical diagnosis and treatment.
结果和结论:吸入性伊洛前列素治疗可以降低肺血管阻力和延缓原发性肺动脉高压的进程。
Results and Conclusion: Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension.
应用推荐